Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Ong, Ms"" wg kryterium: Autor


Tytuł :
Evidence for Low Residue Diet in the Management of Gastrointestinal Related Conditions
Autorzy :
Chengsi Ong MS (US), RD (US)
Christina Ong MBBS, FRCPCH
Wee Meng Han PhD (UK) SRD (UK)
Pokaż więcej
Temat :
Medicine
Źródło :
Proceedings of Singapore Healthcare, Vol 21 (2012)
Opis pliku :
electronic resource
Relacje :
https://doaj.org/toc/2010-1058; https://doaj.org/toc/2059-2329
Dostęp URL :
https://doaj.org/article/18c73b646a8241429347496d94292582
Czasopismo naukowe
Tytuł :
Human Factors and Ergonomics in the Design of Health Information Technology: Trends and Progress in 2014
Autorzy :
Pelayo, S.
Ong, MS.
Pokaż więcej
Źródło :
IMIA Yearbook of Medical Informatics; August 2015, Vol. 24 Issue: 1 p75-78, 4p
Periodyk
Tytuł :
Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients.
Autorzy :
Labrosse R; Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine, University of Montreal, Montreal, Quebec, Canada; Division of Hematology-Oncology, Department of Pediatrics, Boston Children's Hospital, Boston, Mass.
Barmettler S; Allergy and Clinical Immunology Unit, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Mass.
Derfalvi B; Division of Immunology, Department of Pediatrics, IWK Health Center, Dalhousie University, Halifax, Nova Scotia, Canada.
Blincoe A; Department of Paediatric Immunology and Allergy, Starship Children's Hospital, Auckland, New Zealand.
Cros G; Centre Hospitalier de l'Universite de Montreal, University of Montreal, Montreal, Quebec, Canada.
Lacombe-Barrios J; Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine, University of Montreal, Montreal, Quebec, Canada.
Barsalou J; Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine, University of Montreal, Montreal, Quebec, Canada.
Yang N; Allergy and Clinical Immunology Unit, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Mass.
Alrumayyan N; Division of Immunology, Department of Pediatrics, IWK Health Center, Dalhousie University, Halifax, Nova Scotia, Canada.
Sinclair J; Department of Paediatric Immunology and Allergy, Starship Children's Hospital, Auckland, New Zealand.
Ong MS; Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care, Boston, Mass.
Camargo CA Jr; Allergy and Clinical Immunology Unit, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, Mass; Department of Emergency Medicine, Massachusetts General Hospital, Boston, Mass.
Walter J; Department of Pediatrics, University of South Florida at Johns Hopkins All Children's Hospital, Tampa, Fla; Pediatric Allergy and Immunology, Massachusetts General Hospital, Boston, Mass.
Haddad E; Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine, University of Montreal, Montreal, Quebec, Canada; Department of Microbiology, Infectiology and Immunology, Centre Hospitalier Universitaire Sainte-Justine, University of Montreal, Montreal, Quebec, Canada. Electronic address: .
Pokaż więcej
Źródło :
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2021 Aug; Vol. 148 (2), pp. 523-532.e8. Date of Electronic Publication: 2021 Apr 20.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
New-onset Hypogammaglobulinemia and Infectious Complications Associated with Rituximab Use in Childhood-onset Rheumatic Diseases.
Autorzy :
Ong MS; Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care Institute, Boston MA, United States.
Rothman D; Pediatric Rheumatology, Massachusetts General Hospital, Boston MA, United States.
Barmettler S; Allergy and Immunology, Massachusetts General Hospital, Boston MA, United States.
Son MB; Pediatric Rheumatology, Boston Children's Hospital, Boston MA, United States.
Lo M; Pediatric Rheumatology, Boston Children's Hospital, Boston MA, United States.
Roberts J; Pediatric Rheumatology, Boston Children's Hospital, Boston MA, United States.
Natter M; Pediatric Rheumatology, Massachusetts General Hospital, Boston MA, United States.; Computational Health Informatics Program, Boston Children's Hospital, Boston MA, United States.; Department of Pediatrics, Harvard Medical School, Boston MA, United States.
Pokaż więcej
Źródło :
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2021 Jul 30. Date of Electronic Publication: 2021 Jul 30.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Improved Disease Course Associated With Early Initiation of Biologics in Polyarticular Juvenile Idiopathic Arthritis: Trajectory Analysis of a Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans Study.
Autorzy :
Ong MS; Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
Ringold S; Seattle Children's Hospital, Seattle, Washington.
Kimura Y; Joseph M. Sanzari Children's Hospital and Hackensack Meridian School of Medicine, Hackensack, New Jersey.
Schanberg LE; Duke University Medical Center, Durham, North Carolina.
Tomlinson GA; University of Toronto, Toronto, Ontario, Canada.
Natter MD; Boston Children's Hospital, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts.
Pokaż więcej
Corporate Authors :
and the CARRA Registry Investigators
Źródło :
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2021 Jun 08. Date of Electronic Publication: 2021 Jun 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Risk factors for suicide attempt in children, adolescents, and young adults hospitalized for mental health disorders.
Autorzy :
Ong MS; Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Lakoma M; Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Gees Bhosrekar S; Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Hickok J; Ondine Biomedical Inc, Vancouver, BC, Canada.
McLean L; HCA Healthcare, Nashville, TN, USA.
Murphy M; American Addiction Centers, Brentwood, TN, USA.
Poland RE; Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA, USA.; HCA Healthcare, Nashville, TN, USA.
Purtell N; HCA Healthcare, Nashville, TN, USA.
Ross-Degnan D; Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Pokaż więcej
Źródło :
Child and adolescent mental health [Child Adolesc Ment Health] 2021 May; Vol. 26 (2), pp. 134-142. Date of Electronic Publication: 2020 Jun 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis.
Autorzy :
Datta A; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.
Deng S; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.
Gopal V; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.
Yap KC; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.
Halim CE; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.
Lye ML; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.
Ong MS; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.
Tan TZ; Cancer Science Institute of Singapore, National University of Singapore, Singapore 117593, Singapore.
Sethi G; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.; Cancer Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.
Hooi SC; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.; Cancer Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.
Kumar AP; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore 117593, Singapore.; Cancer Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.; National University Cancer Institute, National University Health System, Singapore 119074, Singapore.
Yap CT; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.; Cancer Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore.; National University Cancer Institute, National University Health System, Singapore 119074, Singapore.
Pokaż więcej
Źródło :
Cancers [Cancers (Basel)] 2021 Apr 14; Vol. 13 (8). Date of Electronic Publication: 2021 Apr 14.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Geographical Distribution, Incidence, Malignancies, and Outcome of 136 Eastern Slavic Patients With Nijmegen Breakage Syndrome and NBN Founder Variant c.657_661del5.
Autorzy :
Sharapova SO; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
Pashchenko OE; Immunology Department, Pirogov Russian National Research Medical University, Moscow, Russia.
Bondarenko AV; Department of Pediatric Infectious Diseases and Pediatric Immunology, Shupyk National Medical Academy of Postgraduate Education, Kiev, Ukraine.
Vakhlyarskaya SS; Clinical Immunology and Rheumatology Department, Russian Children's Clinical Hospital of Pirogov Russian National Research Medical University, Moscow, Russia.
Prokofjeva T; Pediatric Clinic, Children's Clinical University Hospital, Riga, Latvia.
Fedorova AS; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
Savchak I; Pediatric Department, West-Ukrainian Specialized Children's Medical Center, Lviv, Ukraine.
Mareika Y; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
Valiev TT; Chemotherapy Hemoblastoses Department, Pediatric Oncology and Hematology Research Institute of N.N. Blokhin National Cancer Research Center of the Ministry of Health of Russian Federation, Moscow, Russia.
Popa A; Propedevtica of Childhood Diseases Faculty, Pirogov Russian National Research Medical University, Moscow, Russia.
Tuzankina IA; Institute of Immunology and Physiology of the Branch of the Russian Academy of Sciences, Federal State Autonomous Educational Intuition of Higher Professional Education (Ural Federal University of a Name of the First President of Russia, B.N. Yeltsin), Yekaterinburg, Russia.
Vlasova EV; Clinical Department, Regional Children's Clinical Hospital №1, Yekaterinburg, Russia.
Sakovich IS; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
Polyakova EA; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
Rumiantseva NV; Research Department, Republican Medical Center (Mother and Child), Minsk, Belarus.
Naumchik IV; Research Department, Republican Medical Center (Mother and Child), Minsk, Belarus.
Kulyova SA; Pediatric Oncology Department, N.N. Petrov National Medical Research Center of Oncology, St-Petersburg, Russia.
Aleshkevich SN; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
Golovataya EI; Research Department, Republican Medical Center (Mother and Child), Minsk, Belarus.
Minakovskaya NV; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
Belevtsev MV; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
Latysheva EA; Immunopathology Department, NRC Institute of Immunology FMBA, Moscow, Russia.
Latysheva TV; Immunopathology Department, NRC Institute of Immunology FMBA, Moscow, Russia.
Beznoshchenko AG; Department of Pediatric Oncology/Hematology, Regional Children's Hospital, Ryazan, Russia.
Akopyan H; Institute of Hereditary Pathology of National Academy of Medical Sciences of Ukraine, Lviv, Ukraine.
Makukh H; Institute of Hereditary Pathology of National Academy of Medical Sciences of Ukraine, Lviv, Ukraine.
Kozlova O; West-Ukrainian Specialized Children's Medical Center, Lviv, Ukraine.
Varabyou DS; Department of Ecologic Geography, Belarusian State University, Minsk, Belarus.
Ballow M; Department of Pediatrics, University of South Florida at Johns Hopkins All Children's Hospital, Saint Petersburg, FL, United States.
Ong MS; Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care, Boston, MA, United States.
Walter JE; Department Pediatric Allergy/Immunology, University of South Florida at Johns Hopkins All Children's Hospital, Saint Petersburg, FL, United States.
Kondratenko IV; Clinical Immunology and Rheumatology Department, Russian Children's Clinical Hospital of Pirogov Russian National Research Medical University, Moscow, Russia.
Kostyuchenko LV; Pediatric Department, West-Ukrainian Specialized Children's Medical Center, Lviv, Ukraine.
Aleinikova OV; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Jan 08; Vol. 11, pp. 602482. Date of Electronic Publication: 2021 Jan 08 (Print Publication: 2020).
Typ publikacji :
Clinical Trial; Journal Article; Multicenter Study
MeSH Terms :
Cell Cycle Proteins*/genetics
Cell Cycle Proteins*/immunology
Founder Effect*
Hematologic Neoplasms*/genetics
Hematologic Neoplasms*/immunology
Hematologic Neoplasms*/mortality
Lymphoproliferative Disorders*/genetics
Lymphoproliferative Disorders*/immunology
Lymphoproliferative Disorders*/mortality
Nijmegen Breakage Syndrome*/genetics
Nijmegen Breakage Syndrome*/immunology
Nijmegen Breakage Syndrome*/mortality
Nuclear Proteins*/genetics
Nuclear Proteins*/immunology
Adolescent ; Adult ; Child ; Child, Preschool ; Europe, Eastern/epidemiology ; Female ; Follow-Up Studies ; Humans ; Incidence ; Male ; Prevalence ; Quality of Life ; Retrospective Studies
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies